Cargando…
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
BACKGROUND: Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to more advanced stages. The aim here was to investigate stage T1 tumors regarding...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574032/ https://www.ncbi.nlm.nih.gov/pubmed/23356517 http://dx.doi.org/10.1186/1471-2490-13-5 |